Financhill
Back

G1 Therapeutics Stock Predictions

G1 Therapeutics Stock Forecast

  • Is G1 Therapeutics Stock Undervalued?
    The current G1 Therapeutics [GTHX] share price is $4.08. The Score for GTHX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • GTHX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will G1 Therapeutics Stock Go Up Next Year?

Data Unavailable

G1 Therapeutics Stock Rating

Data Unavailable

G1 Therapeutics Stock Price History

Is GTHX stock going to rise?

  • The current trend is moderately bearish and GTHX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
stock
Website:
g1therapeutics.com

52-Week Data

52-Week High:
5.00
52-Week Low:
1.08

Prediction Charts

Market Cap:
212.97M
Price in USD:
4.08
Volume:
534.74K
Beta:
1.84

Technical Analysis

SMA50:
3.70
SMA100:
3.35
SMA200:
2.55
52-Wk Change:
53.96%

Stock Predictions

  • Is G1 Therapeutics stock public?
    Yes, G1 Therapeutics is a publicly traded company.
  • What is the G1 Therapeutics stock quote today?
    The G1 Therapeutics stock price is 4.08 USD today.
  • How to buy G1 Therapeutics stock online?
    You can buy G1 Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-27 4.29 4.47 4.77 4.28
Mar-28 4.49 4.32 4.66 4.30
Apr-1 4.31 4.54 4.64 4.17
Apr-2 4.49 4.60 4.67 4.37
Apr-3 4.57 4.72 4.82 4.51
Apr-4 4.77 4.54 4.83 4.46
Apr-5 4.58 4.78 4.83 4.47
Apr-8 4.76 4.77 4.85 4.33
Apr-9 4.77 4.88 4.90 4.65
Apr-10 4.68 4.64 4.68 4.41
Apr-11 4.69 4.68 4.79 4.55
Apr-12 4.65 4.55 4.70 4.39
Apr-15 4.61 4.31 4.61 4.18
Apr-16 4.25 4.08 4.32 3.99

G1 Therapeutics Earnings

Data Unavailable

G1 Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $0.45 per share.

* G1 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.